FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
-18.72%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$79.5M
AUM Growth
+$79.5M
(-61%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-132.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$702K |
Top Sells
| 1 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$106M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Collegium Pharmaceutical
COLL
$1.22B
| $29.4M | 36.98% | 1,887,332 | – | – |
|
|
2
Iovance Biotherapeutics
IOVA
$807M
| $15.2M | 19.14% | 2,188,331 +101,050 | +5% | +$702K |
|
3
Cidara Therapeutics
CDTX
$1.66B
| $13.6M | 17.18% | 1,312,258 | – | – |
|
4
Amicus Therapeutics
FOLD
$2.34B
| $12.9M | 16.26% | 2,600,014 | – | – |
|
|
RXDX
5
DELISTED
Ignyta, Inc.
RXDX
| $5.04M | 6.34% | 950,366 | – | – |
|
|
SRRA
6
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.26M | 4.1% | 2,186,195 | – | – |
|
|
TBRA
7
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| – | – | -2,668,570 | Closed | -$106M |
|